Starlix and Venofer drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Starlix (nateglinide) and Venofer (iron sucrose). Common drug interactions include nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Starlix and Venofer. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Starlix?

Starlix has active ingredients of nateglinide. It is often used in diabetes. eHealthMe is studying from 3,768 Starlix users. Check the latest studies of Starlix.

What is Venofer?

Venofer has active ingredients of iron sucrose. It is often used in anemia. eHealthMe is studying from 8,895 Venofer users. Check the latest studies of Venofer.



On Jul, 28, 2026

13 people who take Starlix and Venofer together, and have interactions are studied.

Starlix and Venofer drug interactions.

What are the common drug interactions of Starlix and Venofer, by gender? *:

female:

n/a

male:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
  3. Skin hypertrophy (skin cells enlarges)
  4. Skin tightness
  5. Myosclerosis (hardening of muscle tissue)
  6. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  7. Rash pruritic (redness with itching)
  8. Skin lesion
  9. Induration (thickening of tissue)
  10. Depression

What are the common drug interactions of Starlix and Venofer, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Depression
  3. Erythema (redness of the skin)
  4. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
  5. General physical health deterioration (weak health status)
  6. Joint contracture (a permanent shortening of a muscle or joint)
  7. Joint range of motion decreased (disease of joint movement)
  8. Joint stiffness
  9. Joint swelling
  10. Mobility decreased (ability to move is reduced)

50-59:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
  3. Skin hypertrophy (skin cells enlarges)
  4. Skin tightness
  5. Myosclerosis (hardening of muscle tissue)
  6. Induration (thickening of tissue)
  7. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  8. Rash pruritic (redness with itching)
  9. Skin lesion
  10. General physical health deterioration (weak health status)

60+:

n/a

What are the existing conditions these people have? *

  1. Nuclear Magnetic Resonance Imaging Brain: 5 people, 38.46%
  2. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take Starlix and Venofer?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Starlix and Venofer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Starlix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Venofer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Starlix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Venofer and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nateglinide and iron sucrose (the active ingredients of Starlix and Venofer, respectively), and Starlix and Venofer (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: